Working… Menu
Trial record 2 of 9 for:    MOR208

Study to Evaluate Safety and Preliminary Efficacy of Tafasitamab (MOR208) With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi (COSMOS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02639910
Recruitment Status : Active, not recruiting
First Posted : December 28, 2015
Last Update Posted : October 18, 2019
Information provided by (Responsible Party):
MorphoSys AG

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : November 2018
Study Completion Date : No date given